SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-470858
Filing Date
2012-11-14
Accepted
2012-11-14 16:50:05
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398952d10q.htm 10-Q 714560
2 EX-10.1 d398952dex101.htm EX-10.1 73824
3 EX-10.2 d398952dex102.htm EX-10.2 73591
4 EX-10.3 d398952dex103.htm EX-10.3 67095
5 EX-31.1 d398952dex311.htm EX-31.1 6764
6 EX-31.2 d398952dex312.htm EX-31.2 6858
7 EX-32.1 d398952dex321.htm EX-32.1 4337
  Complete submission text file 0001193125-12-470858.txt   5041145

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ngsx-20120930.xml EX-101.INS 648630
9 XBRL TAXONOMY EXTENSION SCHEMA ngsx-20120930.xsd EX-101.SCH 46622
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ngsx-20120930_cal.xml EX-101.CAL 59213
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ngsx-20120930_def.xml EX-101.DEF 121955
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngsx-20120930_lab.xml EX-101.LAB 326291
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngsx-20120930_pre.xml EX-101.PRE 238662
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Filer) CIK: 0001385830 (see all company filings)

IRS No.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33438 | Film No.: 121205488
SIC: 2834 Pharmaceutical Preparations